CyclophosphamideVarious toxicities and off-label use: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1943卷 / 1期

关键词：

D O I：

10.1007/s40278-023-33129-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：244 / 244

相关论文

共 50 条

[31] Multiple drugsVarious toxicities and off-label use: 10 case reports
Reactions Weekly, 2021, 1847 (1) : 340 - 342
[32] ImatinibVarious toxicities following off-label use: 5 case reports
Reactions Weekly, 2021, 1876 (1) : 164 - 164
[33] LetrozoleVarious toxicities during off-label use: 7 case reports
Reactions Weekly, 2023, 1952 (1) : 209 - 209
[34] Multiple drugsVarious toxicities and off-label use: 37 case reports
Reactions Weekly, 2023, 1964 (1) : 325 - 325
[35] TocilizumabVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2023, 1973 (1) : 264 - 264
[36] UstekinumabVarious toxicities following off-label use: 5 case reports
Reactions Weekly, 2019, 1774 (1) : 300 - 300
[37] AmisulprideVarious toxicities following off-label use: 6 case reports
Reactions Weekly, 2019, 1766 (1) : 22 - 23
[38] IbrutinibVarious toxicities due to off-label use: 14 case reports
Reactions Weekly, 2020, 1827 (1) : 168 - 168
[39] Multiple drugsVarious toxicities and off-label use: 2 case reports
Reactions Weekly, 2023, 1958 (1) : 392 - 392
[40] MemantineVarious toxicities following off-label use: 8 case reports
Reactions Weekly, 2021, 1867 (1) : 246 - 246

← 1 2 3 4 5 →